31 March 2017 1 Min Read
GREAT REPEAL BILL
Britain details shift from EU laws after Brexit
Drug makers are concerned that Brexit will mean the UK leaves the EU-wide European Medicines Agency, forcing the creation of a separate British system for drug approvals
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In